You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

CLINICAL TRIALS PROFILE FOR DESIPRAMINE HYDROCHLORIDE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for DESIPRAMINE HYDROCHLORIDE

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00000202 ↗	Buprenorphine Maintenance for Opioid Addicts - 1	Completed	National Institute on Drug Abuse (NIDA)	Phase 2	1988-08-01	The purpose of this study is to evaluate the efficacy of buprenorphine and desipramine in treatment of opiate and cocaine dependence.
NCT00000202 ↗	Buprenorphine Maintenance for Opioid Addicts - 1	Completed	Yale University	Phase 2	1988-08-01	The purpose of this study is to evaluate the efficacy of buprenorphine and desipramine in treatment of opiate and cocaine dependence.
NCT00000212 ↗	IV Cocaine Abuse: A Laboratory Model - 1	Completed	Columbia University	Phase 2	1987-07-01	The purpose of this study is to evaluate the effects of desipramine DMI maintenance on cocaine taking and on the physiological and subjective effects of cocaine, including cocaine craving.
NCT00000212 ↗	IV Cocaine Abuse: A Laboratory Model - 1	Completed	National Institute on Drug Abuse (NIDA)	Phase 2	1987-07-01	The purpose of this study is to evaluate the effects of desipramine DMI maintenance on cocaine taking and on the physiological and subjective effects of cocaine, including cocaine craving.
NCT00000212 ↗	IV Cocaine Abuse: A Laboratory Model - 1	Completed	New York State Psychiatric Institute	Phase 2	1987-07-01	The purpose of this study is to evaluate the effects of desipramine DMI maintenance on cocaine taking and on the physiological and subjective effects of cocaine, including cocaine craving.
NCT00000217 ↗	Pharmacotherapy and Intensive Treatment of Drug Abuse - 1	Completed	National Institute on Drug Abuse (NIDA)	Phase 2	1990-09-01	The purpose of this study is to evaluate desipramine and carbamazepine in reducing cocaine craving; increase outpatient treatment capacity and evaluate their incidence of psychiatric disorders.
NCT00000217 ↗	Pharmacotherapy and Intensive Treatment of Drug Abuse - 1	Completed	US Department of Veterans Affairs	Phase 2	1990-09-01	The purpose of this study is to evaluate desipramine and carbamazepine in reducing cocaine craving; increase outpatient treatment capacity and evaluate their incidence of psychiatric disorders.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for DESIPRAMINE HYDROCHLORIDE

Condition Name

Chart
Table

Condition Name for DESIPRAMINE HYDROCHLORIDE
Intervention	Trials
Depression	13
Substance-Related Disorders	6
Cocaine-Related Disorders	5
Schizophrenia	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for DESIPRAMINE HYDROCHLORIDE
Intervention	Trials
Depression	16
Depressive Disorder	9
Substance-Related Disorders	6
Disease	6
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for DESIPRAMINE HYDROCHLORIDE

Trials by Country

Map
Table

Trials by Country for DESIPRAMINE HYDROCHLORIDE
Location	Trials
United States	53
Switzerland	3
Canada	3
France	2
United Kingdom	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for DESIPRAMINE HYDROCHLORIDE
Location	Trials
California	9
New York	7
Massachusetts	5
Missouri	4
Connecticut	4
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for DESIPRAMINE HYDROCHLORIDE

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for DESIPRAMINE HYDROCHLORIDE
Clinical Trial Phase	Trials
Phase 4	13
Phase 3	9
Phase 2	18
[disabled in preview]	20
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for DESIPRAMINE HYDROCHLORIDE
Clinical Trial Phase	Trials
Completed	50
Terminated	4
Unknown status	2
[disabled in preview]	5
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for DESIPRAMINE HYDROCHLORIDE

Sponsor Name

Chart
Table

Sponsor Name for DESIPRAMINE HYDROCHLORIDE
Sponsor	Trials
National Institute on Drug Abuse (NIDA)	10
VA Office of Research and Development	7
New York State Psychiatric Institute	4
[disabled in preview]	14
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for DESIPRAMINE HYDROCHLORIDE
Sponsor	Trials
Other	71
NIH	19
Industry	17
[disabled in preview]	11
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.